Down -25.59% in 4 Weeks, Here's Why CytomX Therapeutics (CTMX) Looks Ripe for a Turnaround [Yahoo! Finance]
CytomX Therapeutics, Inc. (NASDAQ: CTMX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
CytomX Therapeutics Inc (CTMX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]
CytomX Therapeutics (CTMX) Q3 Earnings and Revenues Top Estimates [Yahoo! Finance]
CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]